Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Parasite’s enzyme structure helps address a public health issue

06.01.2004


By revealing the architecture of an essential enzyme in a parasite, Dartmouth researchers are helping address a public health issue.



Researchers in the laboratory of Amy Anderson, Assistant Professor of Chemistry, have unveiled the structure of an enzyme called dihydrofolate reductase-thymidylate synthase, also known as DHFR-TS, from a waterborne parasite called Cryptosporidium hominis. Knowing the chemical structure of the enzyme will help researchers design highly targeted drugs to combat the parasite, which needs this enzyme to reproduce.

"We wanted to know how DHFR-TS is assembled and how it works," says Anderson. "Then we’ll know how to disable it and kill the parasite."


Anderson, along with Robert O’Neil, a senior researcher and the lead author of the study, Ryan Lilien, an M.D./Ph.D. graduate student at Dartmouth, Bruce Donald, Professor of Computer Science, and Robert Stroud, Biochemistry and Biophysics Professor at Univ. of Calif. at San Francisco, have solved the puzzle of DHFR-TS by revealing its chemical architecture.

Their results were electronically published on October 9 in an online issue of the Journal of Biological Chemistry, and the paper appeared in the print edition of the journal on December 26, 2003. The study was also rated as "exceptional" and a "hidden jewel in microbiology" by the Faculty of 1000, a group of researchers who rate published articles in the life sciences each month.

The Centers for Disease Control and Prevention (CDC) have been watching Cryptosporidium and tracking its impact on human populations, where it spreads easily and quickly, for more than 20 years. While healthy people stricken with this parasite usually recover on their own, it can be deadly for children, elderly people and those whose immune systems are compromised, like people with HIV/AIDS or patients undergoing chemotherapy. According to the CDC Web site, Cryptosporidium is often found in public water supplies in the U.S. and cannot be easily filtered out or killed by traditional treatments like chlorine. Currently, there is no cure, and available medicine only eases the symptoms.

The study helps better define the evolution of this protozoan family that includes Plasmodium, which causes malaria, and Toxoplasma, which induces toxoplasmosis, a disease that can lead to central nervous system disorders. Knowing how this one enzyme is assembled will help researchers better understand related parasites, Anderson says.

"By using the structure of many protozoan DHFR-TS enzymes, we’ve been able to place a number of protozoa in distinct evolutionary families. This is the first time that this enzyme has been used to do this," says Anderson. "It’s an important distinction that helps classify the protozoa, and helps us design more effective drugs to combat them."

To discover DHFR-TS’s nuts and bolts, Anderson and her team used a process called "protein crystallography." The process involves taking DNA from Cryptosporidium and cloning it in the fast-growing bacteria E. coli to harvest large amounts of the target enzyme. Researchers then break E. coli open to release all of its proteins. All of the proteins are mixed with beads, or tags, which "grab" just the DHFR-TS enzyme.

Once DHFR-TS has been isolated, it’s collected in a tube, concentrated and crystallized. The crystal, which is an ordered array of enzyme molecules, is subjected to a powerful X-ray beam. Diffracted X-rays emerge and are imprinted on a film. The researchers use mathematical algorithms to interpret the X-ray data, which eventually reveal the structure of the protein.

"We can place every atom in the protein, and we can chart their interactions," says Anderson. "We learn how the protein is put together and which atoms bond to one another. It’s important to learn the structure of a protein to figure out how it works."

Researchers in Anderson’s lab also work on the same enzyme model for Toxoplasma, cousin to Cryptosporidium. The advantage, Anderson explains, is that by solving this enzyme’s structure for both Cryptosporidium and Toxoplasma, they can better predict how it will look in their other family members, like Plasmodium, the malaria bug.

Anderson’s team is also working on "structure-based drug design" to carefully design drugs to interact with the specific enzyme to influence how the enzyme will function.

"We want to prevent DHFR-TS from doing its job in the parasitic organism without stopping the human enzyme that looks similar," says Anderson. "DHFR and TS have similar functions in humans: they are critical to DNA replication."


The National Institutes of Health funded this study.

Sue Knapp | EurekAlert!
Further information:
http://www.dartmouth.edu/

More articles from Life Sciences:

nachricht More genes are active in high-performance maize
19.01.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht How plants see light
19.01.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>